Kim S - Search Results

1

Tumor immune microenvironment permissive to metastatic progression of ING4-deficient breast cancer.

Tsutsumi E, Macy AM, LoBello J, Hastings KT, Kim S. Tsutsumi E, et al. Among authors: kim s. PLoS One. 2024 Jul 5;19(7):e0304194. doi: 10.1371/journal.pone.0304194. eCollection 2024. PLoS One. 2024. PMID: 38968186 Free PMC article.

2

Cxcl10 Chemokine Induces Migration of ING4-Deficient Breast Cancer Cells via a Novel Cross Talk Mechanism between the Cxcr3 and Egfr Receptors.

Tsutsumi E, Stricklin J, Peterson EA, Schroeder JA, Kim S. Tsutsumi E, et al. Among authors: kim s. Mol Cell Biol. 2022 Feb 17;42(2):e0038221. doi: 10.1128/MCB.00382-21. Epub 2021 Dec 6. Mol Cell Biol. 2022. PMID: 34871062 Free PMC article.

3

Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer.

Byron SA, Min E, Thal TS, Hostetter G, Watanabe AT, Azorsa DO, Little TH, Tapia C, Kim S. Byron SA, et al. Among authors: kim s. PLoS One. 2012;7(10):e46823. doi: 10.1371/journal.pone.0046823. Epub 2012 Oct 4. PLoS One. 2012. PMID: 23056468 Free PMC article.

4

Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells.

Keenen MM, Kim S. Keenen MM, et al. Among authors: kim s. Breast Cancer (Dove Med Press). 2016 Nov 17;8:211-221. doi: 10.2147/BCTT.S119691. eCollection 2016. Breast Cancer (Dove Med Press). 2016. PMID: 27895513 Free PMC article.

5

Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis.

Berger PL, Frank SB, Schulz VV, Nollet EA, Edick MJ, Holly B, Chang TT, Hostetter G, Kim S, Miranti CK. Berger PL, et al. Among authors: kim s. Cancer Res. 2014 Jun 15;74(12):3357-68. doi: 10.1158/0008-5472.CAN-13-3076. Epub 2014 Apr 24. Cancer Res. 2014. PMID: 24762396 Free PMC article.

6

A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis.

Kim S, Welm AL, Bishop JM. Kim S, et al. Cancer Res. 2010 Jun 15;70(12):5155-62. doi: 10.1158/0008-5472.CAN-10-0425. Epub 2010 May 25. Cancer Res. 2010. PMID: 20501848 Free PMC article.

7

A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer.

Kim S, Chin K, Gray JW, Bishop JM. Kim S, et al. Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16251-6. doi: 10.1073/pnas.0407158101. Epub 2004 Nov 4. Proc Natl Acad Sci U S A. 2004. PMID: 15528276 Free PMC article.

8

Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer.

Tapia C, Zlobec I, Schneider S, Kilic E, Güth U, Bubendorf L, Kim S. Tapia C, et al. Among authors: kim s. Hum Pathol. 2011 Jul;42(7):983-90. doi: 10.1016/j.humpath.2010.10.012. Epub 2011 Feb 11. Hum Pathol. 2011. PMID: 21315418 Free PMC article.

9

Single-Cell RNA Sequencing of a Postmenopausal Normal Breast Tissue Identifies Multiple Cell Types That Contribute to Breast Cancer.

Peng S, Hebert LL, Eschbacher JM, Kim S. Peng S, et al. Among authors: kim s. Cancers (Basel). 2020 Dec 4;12(12):3639. doi: 10.3390/cancers12123639. Cancers (Basel). 2020. PMID: 33291647 Free PMC article.

10

PD-1-Associated Gene Expression Signature of Neoadjuvant Trastuzumab-Treated Tumors Correlates with Patient Survival in HER2-Positive Breast Cancer.

Hendricks WPD, Briones N, Halperin RF, Facista S, Heaton PR, Mahadevan D, Kim S. Hendricks WPD, et al. Among authors: kim s. Cancers (Basel). 2019 Oct 15;11(10):1566. doi: 10.3390/cancers11101566. Cancers (Basel). 2019. PMID: 31618954 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124,345 results

Search Page

Filters